Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
MARKETS

Dr Lal PathLabs Ltd.

BSE: 539524 | NSE: LALPATHLAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE600L01024 | SECTOR: Hospital & Healthcare Services

| BSE 1406.75 -2.65 (-0.19%) | |

BSE Live

Jan 16, 16:01
1406.75 -2.65 (-0.19%)
Volume
AVERAGE VOLUME
5-Day
11,556
10-Day
10,983
30-Day
12,732
9,459

  • Prev. Close

    1409.40

  • Open Price

    1401.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jan 16, 15:58
1397.90 -12.30 (-0.87%)
Volume
AVERAGE VOLUME
5-Day
423,421
10-Day
394,379
30-Day
341,711
521,271

  • Prev. Close

    1410.20

  • Open Price

    1409.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Cash Flow of Dr Lal PathLabs (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 223.20 195.44 168.27 152.48 191.75  
Net CashFlow From Operating Activities 272.00 208.50 189.38 166.67 142.25  
Net Cash Used In Investing Activities -19.50 -92.75 -165.90 -134.49 -148.14  
Net Cash Used From Financing Activities -187.20 -54.33 12.93 -31.59 0.99  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 65.30 61.43 36.41 0.59 -4.89  
Cash And Cash Equivalents Begin of Year 124.00 62.52 26.11 25.38 22.95  
Cash And Cash Equivalents End Of Year 189.30 123.95 62.52 25.97 18.06  
Source : Dion Global Solutions Limited

Results of Dr Lal PathLab

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347